Mesalamine Capsule, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Mesalamine Capsule, Extended Release (capsule, extended release) from Mylan Pharmaceuticals Inc., a Viatris Company with status To Be Discontinued. The shortage was first posted on 08/25/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Mylan Pharmaceuticals Inc., a Viatris Company
- Package NDC
- 0378-1375-78
- Dosage Form
- Capsule, Extended Release
- Presentation
- Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)
- Initial Posting
- 08/25/2026
- Revised Date